NVST Nobel Biocare: צמיחה צפויה ברווח למניה לשנה הבאה

The robotization of implant production and the implementation of AI-driven design are fueling the growth of Envista Holdings (NVST), as confirmed by the aggregate chart on GURU.Markets: analyst expectations for N+1 profit dynamics show an indicator value of 7.00. However, geopolitical risks and logistics disruptions are complicating equipment deliveries, while moderate demand for consumables stabilizes the company's current market positions.
פילוחים אנליטיים של חברת Envista Holdings

This indicator reflects the analysts' consensus forecast for the change in earnings per share (EPS) for the coming year, making it possible to identify valuation overheating relative to actual growth rates. The trend in the forward-looking EPS growth forecast demonstrates how the expansion of Envista Holdings (NVST) into implantology and dental digitalization converts into expected financial results, confirming the issuer's fundamental stability.